showing the working

← Cadrenal Therapeutics

The business behind the dividend

MeasureCVKDMedianFormula
Return on equity-483.3%10.6%Net income ÷ shareholders’ equity
Return on capital employedOperating income ÷ (equity + total debt)
Owner earnings$-13.24m$120.90mNet income + depreciation & amortisation − capital expenditure
Free cash flow$-12.61m$155.08mOperating cash flow − capital expenditure
Operating marginOperating income ÷ revenue
Net marginNet income ÷ revenue
Debt to equityTotal debt ÷ shareholders’ equity
Interest coverOperating income ÷ interest expense
Current ratio2.72x1.55xCurrent assets ÷ current liabilities
Long-term debt to working capitalLong-term debt ÷ (current assets − current liabilities)
Cash conversionOperating cash flow ÷ net income
Accruals-14.7%-3.1%(Net income − operating cash flow) ÷ total assets

Not computed here: Cash conversion, Debt to equity, Long-term debt to working capital, Interest cover, Net margin, Operating margin, Return on capital employed — why a blank is not a zero.

Ten years of it

The same measures, for every year the filings support. One year is a fact; a row is a business.

Measure2025202420232022Median
Return on equity-483.3%-143.2%-108.6%-143.2%
Current ratio2.72x3.77x10.27x0.55x3.77x